Leerink Partners Downgrades Globus Medical (GMED) to Market Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Morgan Stanley Downgrades Globus Medical (GMED) to Equalweight
July 27, 2016 3:02 PM EDTMorgan Stanley downgraded Globus Medical (NYSE: GMED) from Overweight to Equalweight.
For an analyst ratings summary and ratings history on Globus Medical click here. For more ratings news on Globus Medical click here.
Shares of Globus Medical closed at $26.43 yesterday.
... MoreUPDATE: Canaccord Genuity Downgrades Globus Medical (GMED) to Hold
July 27, 2016 7:17 AM EDT(Updated - July 27, 2016 10:39 AM EDT)
Canaccord Genuity downgraded Globus Medical (NYSE: GMED) from Buy to Hold with a price target of $28.00 (from $30.00). Analyst Kyle Rose expressed concerns that its US business slow to regain momentum.
Rose explained, "We... More
Wells Fargo Upgrades Globus Medical (GMED) to Market Perform
July 27, 2016 7:16 AM EDTWells Fargo upgraded Globus Medical (NYSE: GMED) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Globus Medical click here. For more ratings news on Globus Medical click here.
Shares of Globus Medical closed at $26.43 yesterday.
... MoreGlobus Medical (GMED) Reports In-Line Q2 EPS
July 26, 2016 4:41 PM EDTGlobus Medical (NYSE: GMED) reported Q2 EPS of $0.29, in-line with the analyst estimate of $0.29. Revenue for the quarter came in at $137.5 million versus the consensus estimate of $141.78 million.
GUIDANCE:
Globus Medical sees FY2016 EPS of $1.20, versus the consensus of $1.20. Globus... More
